We demonstrated that RNF6 binds to and mediates VIM for multiple atypical polyubiquitinations including K6-, K27-, and K33-linked forms, and stabilizes and activates VIM in CML cells. Here, RNF6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.